Eaton Vance Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3.71M | Buy |
17,715
+27
| +0.2% | +$5.65K | 0.01% | 861 |
|
|
2022
Q2 | $4.17M | Sell |
17,688
-1,365
| -7% | -$322K | 0.01% | 866 |
|
|
2022
Q1 | $3.42M | Buy |
19,053
+18,428
| +2,948% | +$3.31M | ﹤0.01% | 1004 |
|
|
2021
Q4 | $135K | Sell |
625
-1
| -0.2% | -$216 | ﹤0.01% | 1720 |
|
|
2021
Q3 | $0 | Sell |
626
-541
| -46% | – | ﹤0.01% | 2693 |
|
|
2021
Q2 | $210K | Buy |
1,167
+990
| +559% | +$178K | ﹤0.01% | 1588 |
|
|
2021
Q1 | $30K | Buy |
+177
| New | +$30K | ﹤0.01% | 1937 |
|
|
2019
Q2 | – | Sell |
-2,139
| Closed | -$251K | – | 1315 |
|
|
2019
Q1 | $251K | Sell |
2,139
-125
| -6% | -$14.7K | ﹤0.01% | 1174 |
|
|
2018
Q4 | $247K | Sell |
2,264
-568
| -20% | -$62K | ﹤0.01% | 1123 |
|
|
2018
Q3 | $362K | Sell |
2,832
-285
| -9% | -$36.4K | ﹤0.01% | 1090 |
|
|
2018
Q2 | $353K | Sell |
3,117
-3,163
| -50% | -$358K | ﹤0.01% | 1066 |
|
|
2018
Q1 | $706K | Buy |
6,280
+2,357
| +60% | +$265K | ﹤0.01% | 1034 |
|
|
2017
Q4 | $580K | Sell |
3,923
-238
| -6% | -$35.2K | ﹤0.01% | 938 |
|
|
2017
Q3 | $488K | Sell |
4,161
-1
| -0% | -$117 | ﹤0.01% | 954 |
|
|
2017
Q2 | $540K | Sell |
4,162
-54
| -1% | -$7.01K | ﹤0.01% | 925 |
|
|
2017
Q1 | $571K | Sell |
4,216
-1,980
| -32% | -$268K | ﹤0.01% | 877 |
|
|
2016
Q4 | $889K | Buy |
6,196
+63
| +1% | +$9.04K | ﹤0.01% | 749 |
|
|
2016
Q3 | $724K | Sell |
6,133
-18
| -0.3% | -$2.13K | ﹤0.01% | 783 |
|
|
2016
Q2 | $652K | Sell |
6,151
-2,432
| -28% | -$258K | ﹤0.01% | 770 |
|
|
2016
Q1 | $956K | Buy |
8,583
+223
| +3% | +$24.8K | ﹤0.01% | 685 |
|
|
2015
Q4 | $1.31M | Buy |
8,360
+860
| +11% | +$135K | ﹤0.01% | 629 |
|
|
2015
Q3 | $984K | Hold |
7,500
| – | – | ﹤0.01% | 674 |
|
|
2015
Q2 | $1.31M | Hold |
7,500
| – | – | ﹤0.01% | 592 |
|
|
2015
Q1 | $1.29M | Buy |
+7,500
| New | +$1.29M | ﹤0.01% | 629 |
|